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ATP-dependent chromatin-remodeling complexes are conserved among all eukaryotes and function by
altering nucleosome structure to allow cellular regulatory factors access to the DNA. Mammalian SWI-SNF
complexes contain either of two highly conserved ATPase subunits: BRG1 or BRM. To identify cellular genes
that require mammalian SWI-SNF complexes for the activation of gene expression, we have generated cell lines
that inducibly express mutant forms of the BRG1 or BRM ATPases that are unable to bind and hydrolyze ATP.
The mutant subunits physically associate with at least two endogenous members of mammalian SWI-SNF
complexes, suggesting that nonfunctional, dominant negative complexes may be formed. We determined that
expression of the mutant BRG1 or BRM proteins impaired the ability of cells to activate the endogenous stress
response gene hsp70 in response to arsenite, a metabolic inhibitor, or cadmium, a heavy metal. Activation of
hsp70 by heat stress, however, was unaffected. Activation of the heme oxygenase 1 promoter by arsenite or
cadmium and activation of the cadmium-inducible metallothionein promoter also were unaffected by the
expression of mutant SWI-SNF components. Analysis of a subset of constitutively expressed genes revealed no
or minimal effects on transcript levels. We propose that the requirement for mammalian SWI-SNF complexes
in gene activation events will be specific to individual genes and signaling pathways.
The packaging of eukaryotic DNA into nucleosomes and
higher order chromatin structure presents cells with a signifi-
cant barrier to DNA utilization and necessitates mechanisms
by which chromatin structure can be modified so that transcrip-
tion can occur. Many multiprotein complexes with the ability to
modify chromatin structure have been identified. These in-
clude histone acetyltransferases and deacetylases, which di-
rectly modify histone tail domains, and a class of energy-de-
pendent enzymes that utilize ATP hydrolysis to alter
nucleosome structure (reviewed in references 23, 30, 32, 34, 70,
83, and 84). The ATP-dependent chromatin remodeling com-
plexes are conserved among eukaryotes, they share a related
subunit that possesses DNA-stimulated ATPase activity, and
each has been demonstrated to alter nucleosome structure in
vitro in an ATP-dependent manner. Most of these complexes
can be classified into two groups, those containing homologues
of the yeast SWI2-SNF2 ATPase subunit, including yeast SWI-
SNF (7, 12, 55), human SWI-SNF (hSWI-SNF) (24, 35, 82),
yeast RSC (8), and Drosophila BRM complexes (54, 71), and
those containing homologues of the Drosophila imitation-switch
(ISWI) ATPase gene (16), including yeast ISW1 and ISW2
(76), human RSF (39), and the Drosophila NURF, CHRAC,
and ACF complexes (25, 75, 78). A third group can be defined
by Xenopus and human complexes containing the Mi2 protein,
a related ATPase found in association with histone deacetylase
activity (72, 81, 87, 90).
Although members of the ATP-dependent class of chroma-
tin remodelers facilitate alterations in nucleosome structure in
vitro, the cellular role of most of the complexes is not well
defined. The yeast SWI-SNF complex is the prototype for the
ATP-dependent remodeling complexes. Five of the subunits
are encoded by the SWI and SNF genes that were originally
isolated in screens for genes required for mating type switching
or for sucrose fermentation (3, 53, 68). Subsequent work es-
tablished that these genes were required for the optimal ex-
pression of a subset of inducible yeast genes (31, 41, 56, 88) and
for transcription of Ty elements (11, 21, 41). The Drosophila
brm protein, the ATPase subunit of the brm complex, has been
shown to be a regulator of Drosophila homeotic genes (71),
underscoring a role for this complex in developmentally regu-
lated gene expression.
Human SWI-SNF complexes contain either the human
BRM (hBRM) (hSNF2a) or the BRG1 (hSNF2b) homologues
of the yeast SWI2-SNF2 ATPase (10, 29, 51). Components of
hSWI-SNF complexes have been implicated in a range of cel-
lular events, including gene activation, regulation of cell
growth, and development and differentiation (reviewed in ref-
erence 23). Regulation of cell cycle progression may occur via
interaction of BRG1-hBRM with the retinoblastoma oncopro-
tein (Rb) and/or cyclin E (14, 62, 65, 69). In addition, the
complex or individual subunits may be targeted by viral regu-
latory proteins upon infection of cells by adenovirus, Epstein-
Barr virus, human papillomavirus, and human immunodefi-
ciency virus (13, 28, 37, 43, 86). The ini1 subunit has been
shown to interact with the ALL-1 protein, the translocation of
which is a hallmark of several types of human acute leukemias
(58), and ini1 also was found to be altered in human malignant
rhabdoid tumors (79), suggesting a role for ini1 as a tumor
suppressor. Thus, the human SWI-SNF complex not only has a
subunit that may act as a tumor suppressor (ini1) but also
contains other subunits that directly interact with Rb, a known
tumor suppressor. These results strongly implicate human
SWI-SNF complex components in the regulation of cell
growth, possibly via transcriptional control.
Several lines of evidence suggest that human SWI-SNF com-
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plexes may regulate a subset of transcriptional activation
events in cells. Transient transfection of hBRM or BRG1 can
increase gene induction of transfected reporter genes by some
activators, while transfection of these genes mutated in the
ATP binding site abrogates the increase in activation. The
activators affected were limited to c-myc (9) and nuclear hor-
mone receptors, including glucocorticoid receptor (GR), es-
trogen receptor, and retinoic acid receptor (10, 29, 51, 65).
These findings were in agreement with earlier data showing
that expression of rat GR in yeast cells required yeast SWI-
SNF function (89). Additionally, physical association of BRG1
and the hSWI-SNF subunit BAF155 (hSWI3) with GR was
correlated with GR-mediated activation of integrated mouse
mammary tumor virus long terminal repeat (LTR) reporter
genes (17), strongly implicating BRG1 in the activation of this
promoter by GR. Recently, hSWI-SNF complexes were shown
to bind to the C/EBPb activator and facilitate myeloid gene
activation (33). However, in other experiments, repression of
reporter genes by E2F was shown to require BRG1-hBRM
proteins (73), and it was recently reported that BRG1 re-
presses transcription of the endogenous c-fos gene when intro-
duced into cell lines that lack BRG1 and hBRM (52). Thus,
SWI-SNF complexes may positively and negatively affect gene
expression in mammalian cells.
Since there has been little analysis of the effects of hSWI-
SNF and its components on the activation of endogenous cel-
lular genes, we have sought to identify endogenous genes in
mammalian cells that require the activity of mammalian SWI-
SNF complexes. We have created cell lines that inducibly ex-
press either BRG1 or hBRM proteins that are mutated in the
ATP binding site, with the objective of creating conditions in
mammalian cells in which nonfunctional SWI-SNF complexes
might interfere with gene activation events. Having created
such lines, we then asked whether the activation of the hsp70
stress response gene was affected. We chose hsp70 for several
reasons. First, the hsp70 gene is highly inducible and can be
activated by a number of distinct cellular stresses, allowing us
to compare activation of the same gene by different inducers.
Second, there is a wealth of in vitro evidence that indicates that
reconstituted stress response genes can be remodeled in vitro
by Drosophila and mammalian ATP-dependent chromatin-re-
modeling complexes (4, 44, 74, 77, 78).
Here we report that activation of the endogenous hsp70
locus in mammalian cells is partially dependent on the SWI-
SNF components BRG1 and hBRM. This is the first demon-
stration that any ATP-dependent chromatin-remodeling com-
plex is involved in the activation of the stress response genes in
vivo. Interestingly, activation of hsp70 by a metabolic inhibitor
or by a heavy metal showed dependence on the SWI-SNF
components, while activation by heat stress did not. The data
suggest there are multiple pathways for activating hsp70 and
that mammalian SWI-SNF complexes are selectively required
during specific activation events.
MATERIALS AND METHODS
Plasmids. pBS(KS1)CeBRG1 and pBS(KS1)CehBRM (Ce, C-terminal
epitope tagged) carry BRG1 or hBRM coding sequences that contain the Flag
epitope sequence at the 39 end (S. Sif and R. E. Kingston, unpublished data).
To create Flag-tagged BRG1 containing a mutation in the ATP bind-
ing site, an NsiI-BglII restriction fragment was isolated from pBJ5 BRG1 K-R
(29) and cloned into NsiI-BglII-digested pBS(KS1)CeBRG1 to create
pBS(KS1)CeBRG1 K-R. Clones were sequenced to verify the presence of the
mutation. pBS(KS1)CeBRG1 K-R was digested with ClaI and SpeI, as well as
with PvuI (which cuts only the vector) and the 5-kb insert fragment was gel
purified and cloned into ClaI-SpeI cut pTet-Splice (63) to create pTS CeBRG1
K-R. Clones were sequenced to confirm the presence of the K-to-R mutation.
To create Flag-tagged hBRM containing a mutation in the ATP binding site,
a 2.4-kb BglII restriction fragment was isolated from pCG hBRM-NTP (51) and
cloned into BglII-digested pBS(KS1)CehBRM to create pBS(KS1)CehBRM-
NTP. The mutation at the ATP binding site encodes a HindIII restriction site
(51); the presence of this site in selected clones indicated that the mutation had
been incorporated. pBS(KS1)CehBRM-NTP was digested with ClaI and SpeI
(and PvuI to digest vector sequences) and the resulting 5-kb insert fragment
cloned into ClaI-SpeI-digested pTet-Splice to create pTS CehBRM-NTP. Posi-
tive clones were then sequenced to verify the mutation.
Cell lines. All cells were grown in Dulbecco’s modified Eagle’s medium-hi
(DMEM-hi) (Gibco-BRL) supplemented with 10% heat-inactivated calf serum
(Sigma) and 2 mM L-glutamine (Sigma). Mouse NIH 3T3 cells were purchased
from the American Type Culture Collection. One-hundred-millimeter plates of
NIH 3T3 cells that were six passages from receipt were transfected with 16 mg of
pTet-tA, which encodes the tet-VP16 regulator (63), and 4 mg of pRSV-neo by
using the calcium phosphate method (2). After 48 h, 0.12 mg of Geneticin
(Gibco-BRL) per ml was added to the media. Media were changed every 36 to
48 h for 12 days, and drug-resistant colonies were picked and expanded. To test
for expression of the tet-VP16 regulator, clones were washed twice with phos-
phate-buffered saline (PBS), and diluted into 60-mm-diameter plates in the
absence or presence of 2 mg of tetracycline (Sigma) per ml. Forty-eight hours
later, the plates were transiently transfected with 10 ng of pUHC13-3, a lucif-
erase reporter gene under the control of tet operator sites (20), and 9.74 mg of
pBS(SK1) as nonspecific DNA. Cells were harvested 48 h later, and cell extracts
were assayed for luciferase activity by using a Luciferase Assay kit (Promega) in
accordance with the manufacturer’s instructions. One of the clones expressing
high levels of luciferase activity in the absence but not the presence of tetracy-
cline was selected for further use and was renamed tet-VP16.
tet-VP16 cells were maintained in 2 mg of tetracycline per ml and 75 mg of
Geneticin per ml. Cells were plated in 100-mm dishes and transfected via the
calcium phosphate method with 16 mg of pTS CehBRM-NTP or pTS CeBRG1
K-R and 4 mg of pRSV2-hygro, which encodes resistance to hygromycin B. After
48 h, cells were trypsinized and plated at 1:10, 1:20, 1:50, and 1:100 in the
presence of 400 U of hygromycin B (Calbiochem) per ml. The media were
changed every 48 h, and drug-resistant colonies were picked after 13 days.
Following expansion, clones were washed twice with PBS and plated in the
presence or absence of 2 mg of tetracycline per ml such that they were nearly
confluent after 3 days. Western analyses of cell extracts were used to identify
clones expressing 200-kDa Flag-tagged proteins in the absence but not the
presence of tetracycline.
Once generated, all cell lines (except the NIH 3T3 parental line) were main-
tained in 2 mg of tetracycline per ml. B22, B24, H16, and H17 lines were
maintained in tetracycline, Geneticin, and 350 to 400 U of hygromycin B per ml
without exception. Once established, the cell lines, including NIH 3T3 cells, were
passaged twice a week at dilutions generating nearly confluent plates on the next
passage date. For experiments requiring growth in media lacking tetracycline, the
cell lines were always washed twice with PBS before passage.
Protein extracts and analysis of protein expression. For protein isolation,
100-mm plates of cells were scraped into 1 ml of PBS, transferred to a 1.5-ml
Eppendorf tube, and centrifuged at 200 3 g for 1 min. The cell pellet was frozen
in liquid N2 and stored at 280°C or was immediately resuspended in 200 ml of
lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40,
20% glycerol, 1 mM dithiothreitol, 1 mg of pepstatin A per ml, 4 mg of leupeptin
per ml, and 1 mM phenylmethylsulfonyl fluoride. Samples were sonicated twice
for 1 s and were centrifuged for 10 min at 10,000 3 g at 4°C. The supernatant was
removed, and protein levels were quantified by a Bradford assay using bovine
serum albumin as a standard. Extracts were frozen in liquid nitrogen and stored
at 280°C. For the immunoprecipitation experiment, cells were lysed by resus-
pension in lysis buffer, repeatedly passed through a 26-gauge needle, and then
centrifuged at 10,000 3 g at 4°C. The extract (1.0 mg of total protein) was
incubated with 30 ml of M2 beads (Sigma) prewashed in lysis buffer. Samples
were incubated overnight at 4°C on a nutator (Clay-Adams). Samples were then
centrifuged at 4°C for 40 s at 1,500 3 g, and the pellets were washed twice with
a buffer containing 10 mM HEPES (pH 8.0), 150 mM NaCl, 1 mM EDTA, 10%
glycerol, 2 mM dithiothreitol, and 0.1% Triton X-100. The pellets were washed
again in the same buffer containing 50 mM NaCl (instead of 150 mM) and
lacking Triton X-100 and then were subsequently resuspended in sodium dodecyl
sulfate (SDS)-sample loading buffer.
For Western analysis, 30 to 60 mg of total cellular protein was subjected to
SDS-polyacrylamide gel electrophoresis (PAGE) and then transferred to nitro-
cellulose. Immunoblotting was performed with secondary antibody conjugated to
horseradish peroxide and ECL solutions from Amersham. Primary antibodies
used for Flag epitope detection included monoclonal M2 antibody (Kodak and
Sigma) for initial identification of clones expressing Flag-tagged proteins and
rabbit polyclonal anti-Flag antibodies (Santa Cruz or Zymed) for all subsequent
analyses. Rat monoclonal antibody against HSF1 was purchased from LabVision.
Polyclonal rabbit anti-BRG1, anti-mouse BRM (mBRM), and anti-ini1 antibod-
ies were generated against glutathione S-transferase fusion proteins to BRG1
amino acids 214 to 279 (sequence corresponding to that by Chiba et al. [10]), to
mouse BRM sequences corresponding to amino acids 48 to 214 of the human
BRM sequence (49) or to the entire ini1 coding sequence (28). The antiserum
against hSWI3 has been described (64).
RNA isolation and expression assays. Total cellular RNA was isolated by
using TRIzol (Gibco-BRL) as described by the manufacturer. For Northern
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analysis, 15 mg of total cellular RNA was subjected to electrophoresis on a 1.2%
agarose gel and transferred to nitrocellulose (see Fig. 3) or Nytran Plus (see Fig.
9; Schleicher & Schuell) by using 103 SSC (13 SSC is 0.15 M NaCl plus 0.015
M sodium citrate). Following UV cross-linking, the filter was prehybridized for
at least 6 h at 42°C in 50% formamide, 53 SSC or 63 SSPE (13 SSPE is 0.18
M NaCl, 10 mM NaH2PO4, and 1 mM EDTA [pH 7.7]), 10% dextran sulfate, 20
mM Tris-HCl (pH 7.5), 13 Denhardt’s solution, and 100 mg of sheared salmon
sperm DNA per ml.
Gel-isolated restriction fragments were random primed with [a-32P]dATP
(NEN) and DNA polymerase 6 Klenow fragment (NEB), purified over a Seph-
adex G50 spin column, denatured, and used as a probe for Northern analyses.
Following a 16- to 24-h hybridization at 42°C, the filters were rinsed in 23
SSC–0.1% SDS (see Fig. 3) or 63 SSPE–0.1% SDS (see Fig. 9) and were washed
twice at room temperature for 15 min and once at 42°C for 10 min in the same
buffer. Hybridization was analyzed by a PhosphorImager, and quantification was
performed by using ImageQuant software (Molecular Dynamics). The filters
were stripped and reprobed as indicated in the figure legends. As shown in Fig.
3, hsp70 levels were normalized to GAPDH (glyceraldehyde-3-phosphate dehy-
drogenase) levels for quantitation. Primer extension analysis was performed with
15 to 20 mg of total cellular RNA as previously described (2), except that
one-tenth of the suggested amount of salmon sperm DNA was used in the RNase
buffer. Oligonucleotides used for hybridizations corresponded to nucleotides 660
to 635 of mouse hsp70 (22), to nucleotides 33 to 14 of the published mouse
GAPDH sequence (59), to nucleotides 61 to 80 relative to the mouse heme
oxygenase 1 (HO-1) start site (1), and to nucleotides 604 to 585 of mouse
metallothionein I (Mt I) (19). Quantification was performed as described above.
RESULTS
To identify mammalian genes regulated by BRG1 or hBRM
containing chromatin-remodeling complexes, we designed a
strategy to create cell lines that inducibly express dominant
negative versions of BRG1 or hBRM. We chose to utilize
BRG1 and hBRM genes mutated in the ATP binding site (29,
51), since previous studies indicated that whereas transient
transfection of wild-type BRG1 or hBRM could augment ac-
tivation of some reporter genes, transfection of these ATP
binding site mutants did not. We hypothesized that when ex-
pressed, the mutant forms would be competent for SWI-SNF
complex formation, resulting in the assembly of nonfunctional
complexes, and that gene activation events that required
BRG1 or hBRM chromatin-remodeling complexes would
therefore be impaired or inhibited.
An inducible expression system was chosen because prior
studies had shown that in some cell types, BRG1 and hBRM
could interact with the Rb oncoprotein and induce cell cycle
arrest (14, 69) which, if universally true for all cell types, might
preclude isolation of stably expressing cell lines. We utilized
the tetracycline-inducible expression system described by Gos-
sen and Bujard (20) with the modifications of Shockett et al.
(63). NIH 3T3 cells were stably transformed with the tet-VP16
regulator and a gene encoding neomycin resistance. Drug-
resistant colonies were screened for the ability to activate a
transiently transfected luciferase reporter under the control of
tet operator sites (20). One of the clones that expressed high
levels of luciferase in the absence but not the presence of
tetracycline was chosen for further manipulation and was
named tet-VP16. tet-VP16 cells were stably transformed with a
gene encoding hygromycin B resistance and a tet operator-
controlled vector containing either Flag-tagged hBRM (f-
hBRM) mutated at the ATP binding site or Flag-tagged BRG1
(f-BRG1) mutated at the ATP binding site. Drug-resistant
clones were analyzed for expression of Flag-tagged proteins
when grown in the absence but not the presence of tetracycline
FIG. 1. (A) Time course of Flag-tagged protein expression. Cell lines were washed twice with PBS and diluted into media containing or lacking tetracycline such
that plates were nearly confluent on the days indicated. Cells were harvested, cell pellets were extracted, and Western analysis was performed by using an anti-Flag
antibody to detect levels of Flag-tagged protein. (B and C) Comparative analysis of Flag-tagged protein levels in each cell line. (B) Total cell extract (10, 20, 40, or 60
mg) from each of the B lines or each of the H lines was used for Western analysis with anti-Flag antibody. (C) Anti-Flag immunoreactivity from 60 mg of H17 and H16
extracts was compared to anti-Flag immunoreactivity from 2.5, 5, 10, 20, 40, or 60 mg of B22 extract.
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by Western blotting with an anti-Flag antibody. Ten of 33 drug
resistant clones transformed with the f-hBRM mutant yielded
tet-specific inducible expression; 5 of 27 drug-resistant clones
transformed with the f-BRG1 mutant yielded tet-specific in-
ducible expression.
Three of the lines expressing epitope-tagged mutant BRG1
(B22, B24, and B05-1) and two lines expressing epitope-tagged
mutant hBRM (H16 and H17) were chosen for further study.
A time course of Flag-tagged protein expression was per-
formed for each of the cell lines. Cells were plated at different
dilutions in the presence or absence of tetracycline such that
on the days indicated the plates were nearly confluent. Cell
extracts were analyzed for Flag immunoreactivity by Western
blotting, and the results for each of the cell lines are shown in
Fig. 1A. Each of the lines yielded inducible expression; how-
ever, clear differences between the lines were observed. B24
and B05-1 cells both showed some leakiness, as low levels of
f-BRG1 were present in the presence of tetracycline; however,
induced f-BRG1 levels remained high at day 8 in B24 cells,
whereas in B05-1 cells a peak of expression occurred at days 3
and 4, followed by a reduction in the f-BRG1 levels on days 6
and 8. The f-hBRM mutant lines both maintained Flag-tagged
protein levels through day 8; however, the H16 line repeatedly
took longer to induce expression than did the H17 line. It is
important to note that there was some inherent variability in
the amount of Flag-tagged protein expressed in the presence of
tetracycline from experiment to experiment. Thus, for all ex-
periments in which transcript levels were analyzed (see Fig. 3
to 6, 8, and 9), duplicate plates were used to make protein
extracts to correlate mRNA levels with Flag-tagged protein
levels.
To allow us to analyze all of the cell lines in parallel, we
chose day 4 after removal of tetracycline as the time point at
which to do experiments, as we hypothesized that this would
allow the mutant proteins sufficient time to become incorpo-
rated into SWI-SNF complexes. In addition, B05-1 cells at day
4 still contained significant levels of f-BRG1.
To determine the relative amounts of Flag-tagged protein
expression produced by the different lines, we analyzed in-
creasing amounts of day 4 protein extract for Flag immunore-
activity (Fig. 1B and C). The results indicate that the f-BRG1-
expressing lines produce similar amounts of Flag-tagged
protein. The f-hBRM-expressing lines also expressed some-
what similar levels of Flag-tagged protein. It appeared that the
H17 and H16 lines produced less Flag-tagged protein than did
the f-BRG1-expressing lines, so to compare relative expression
levels, 60 mg of H16 and H17 day 4 protein extract was com-
pared to a range of B22 day 4 protein levels (Fig. 1C). The
results indicate that B22 cells express approximately threefold
more Flag-tagged protein than H17 cells do and approximately
sixfold more protein than do H16 cells.
We immunoprecipitated Flag-tagged proteins from day 4
extracts to analyze whether other SWI-SNF subunits were as-
sociated with the Flag-tagged mutant proteins (Fig. 2). Bead-
bound M2 anti-Flag monoclonal antibody was used for the
immunoprecipitation, and the immunoprecipitated material
was subjected to SDS-PAGE and Western blotting. Probing
the blots with anti-Flag antibody showed the presence of in-
FIG. 2. Flag-tagged mutant BRG1 and hBRM coimmunoprecipitate with endogenous ini1 and SWI3 subunits. Cell lines were grown in the presence or absence
of tetracycline for 4 days. Cell pellets were extracted and immunoprecipitated with anti-Flag bound beads. The immunoprecipitated material was subjected to Western
analysis with anti-Flag antibody. The filters were stripped and reprobed sequentially with antisera to BRG1, mouse BRM, and a human SWI3 homologue. Duplicate
samples were run on an SDS–10% PAGE gel and probed with the ini1 antisera.
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ducible Flag-tagged protein in the mutant lines but not in the
parental NIH 3T3 or tet-VP16 lines. The membranes were
then stripped and reprobed sequentially with antibodies to
BRG1, mBRM, and a human SWI3 homologue (BAF 155).
Duplicate samples run on a higher percentage SDS-PAGE gel
were probed for ini1. ini1 and the SWI3 homologue are com-
ponents of both BRG1 and hBRM complexes (49, 50, 82).
When probed with BRG1 antibody, only the B lines showed
immunoreactivity dependent on the removal of tetracycline,
whereas only the H lines showed immunoreactivity when
probed with mBRM antibody. These results confirm the iden-
tity of the Flag-tagged protein present in each of the cell lines
and demonstrate the specificity of the two antibodies. In addi-
tion, we have confirmed that hBRM and BRG1 proteins do not
coimmunoprecipitate, indicating that BRG1 and hBRM likely
do not associate with each other. This result is in agreement
with previously reported data (82). When the membranes were
probed for ini1 or the SWI3 homologue, we observed that both
proteins coimmunoprecipitated with the f-BRG1 as well as the
f-hBRM mutant proteins in a tet-inducible manner, indicating
that both f-BRG1 and f-hBRM mutant proteins were associ-
ated with the endogenous ini1 and SWI3 proteins and were
likely forming ATPase-deficient SWI-SNF complexes.
We then set out to determine whether expression of the
mutant Flag-tagged proteins affected specific gene activation
events. We chose to analyze the expression of the hsp70 stress
response gene, since chromatin remodeling of Drosophila and
mammalian hsp70 loci has been used as an in vitro assay in the
identification and characterization of ATP-dependent nucleo-
some-remodeling factors, including NURF, and hSWI-SNF (4,
74, 77). Additionally, hsp70 expression can be activated by a
number of different kinds of environmental stress, thereby
affording us the opportunity to assess the involvement of
BRG1- and BRM-based remodeling complexes in hsp70 induc-
tion by different stimuli.
We first analyzed the induction of hsp70 in the presence of
the metabolic inhibitor, sodium arsenite. Parental and mutant
cell lines were plated in duplicate in the presence or absence of
tetracycline. On day 4, cells were mock treated or treated with
100 mM sodium arsenite for 8 h, at which time plates were
harvested for protein or RNA isolation. Northern blot analysis
of mRNA levels shows induction of hsp70 message in arsenite-
treated parental NIH 3T3 and tet-VP16 cell lines (Fig. 3, lanes
1, 2, and 3 to 6). Since tet-VP16 cells contain the tet regulator
but no target gene, the presence or absence of tetracycline had
no effect on the level of hsp70 mRNA produced (Fig. 3, com-
pare lanes 5 and 6). In contrast, hsp70 levels in cells expressing
mutant f-BRG1 or mutant f-hBRM were reduced when tetra-
cycline was removed, compared to hsp70 levels from cells
grown in the presence of tetracycline (compare lanes 9 and 10,
13 and 14, 17 and 18, and 21 and 22). Western analysis of
protein samples indicates that the decrease in hsp70 levels in
the mutant cell lines correlated with expression of the mutant
Flag-tagged protein. Quantification of hsp70 mRNA levels in
this experiment indicated a 2.5- to 5.0-fold reduction in hsp70
induction by sodium arsenite when the mutant f-BRG1 or
f-hBRM was expressed. We conclude that expression of the
mutant proteins partially inhibits activation of hsp70 by sodium
arsenite, likely by acting as a dominant negative. These results
strongly suggest that hBRM- and/or BRG1-based chromatin-
remodeling complexes contribute to the induction of the en-
dogenous hsp70 loci upon exposure to sodium arsenite.
Since inducible hsp70 is part of a family of related genes, we
were concerned that Northern analysis might reflect the ex-
pression of several different genes. We therefore repeated the
experiment with a primer extension assay with oligonucleotide
probes against a specific mouse hsp70 gene (hsp70.1, referred
to as hsp70 hereafter) (22) and against mouse GAPDH (59) as
a control. Extension products were resolved on a sequencing
gel and are shown in Fig. 4. Analysis of the f-BRG1 mutant
lines indicates that removal of tetracycline resulted in a de-
creased level of hsp70 mRNA upon sodium arsenite stimula-
tion (Fig. 4A) and a corresponding induction in the levels of
f-BRG1 mutant protein (Fig. 4B). Similarly, analysis of the
f-hBRM mutant lines demonstrates that tetracycline removal
resulted in a decreased level of hsp70 mRNA in response to
FIG. 3. Expression of Flag-tagged mutant BRG1 or hBRM partially inhibits sodium arsenite-mediated activation of hsp70. Cell lines grown in the presence or
absence of tetracycline for 4 days were treated with 100 mM sodium arsenite for 8 h. Total cellular RNA was prepared and subjected to Northern blot analysis. Blots
were probed for mouse hsp70 by using a 1.8-kb restriction fragment from pM1.8 (22), stripped, and reprobed with a 700-bp EcoRI-HindIII cDNA fragment encoding
human GAPDH. Quantification was performed on a Molecular Dynamics PhosphorImager using ImageQuant software. Duplicate plates were used to make protein
extracts, which were used for Western analysis to confirm the expression of Flag-tagged mutant BRG1 or hBRM in each cell line.
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sodium arsenite stimulation (Fig. 4C) as well as a correspond-
ing induction in the levels of f-hBRM mutant protein (Fig.
4D). Thus, the primer extension assays confirm the results of
the Northern analysis and further support a role for BRG1
and/or BRM chromatin-remodeling complexes in sodium ar-
senite-mediated activation of the hsp70 gene. Quantification of
results from multiple experiments is presented in Fig. 4E as the
decrease in fold activation due to expression of the dominant
negative BRG1 or hBRM. A value of 1.0 indicates that no
decrease in the level of activation occurred. In most of the cell
lines, approximately four- to fivefold less hsp70 mRNA was
present in the absence of tetracycline as compared to that in
the presence of tetracycline.
Because multiple stresses can activate the hsp70 genes, we
analyzed the activation of hsp70 in response to Cd21, a heavy
metal. Cell lines were maintained in the presence or absence of
tetracycline for 4 days and subsequently were exposed to 20
mM CdCl2 for 24 h. Analysis of mRNA and protein levels is
presented in Fig. 5A and B. As in the case of sodium arsenite
stimulation, activation of hsp70 by CdCl2 in the presence or
absence of tetracycline was not significantly different in the
tet-VP16 cells (lanes 3 and 4). In contrast, activation of hsp70
by CdCl2 in the mutant lines was partially inhibited when the
mutant Flag-tagged protein was expressed (lanes 7 and 8, 11
and 12, 15 and 16, and 19 and 20). Quantification revealed that
expression of the mutant proteins resulted in a three- to four-
fold decrease in activation (Fig. 5C).
Previous studies have suggested that activation of hsp70
genes by heat shock may occur via a different pathway than
does activation by other stress inducers like sodium arsenite or
FIG. 4. Primer extension analysis demonstrating that expression of Flag-
tagged mutant BRG1 or hBRM partially inhibits sodium arsenite-mediated ac-
tivation of hsp70. Cell lines were grown as described for Fig. 4. (A and C) Total
cellular RNA was used for primer extension analysis with primers complemen-
tary to mouse GAPDH (59) and mouse hsp70.1 (22). (B and D) Duplicate plates
were used to make protein extracts, which were used for Western analysis to
confirm the expression of Flag-tagged mutant BRG1 or hBRM in each cell line.
M, mock-treated cells; A, arsenite-treated cells. (E) Quantification of the de-
crease in activation of hsp70 by arsenite in the presence of the dominant negative
proteins. Data points with error bars represent the average of three or four
experiments; those without error bars are the average of two experiments.
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cadmium chloride (38, 48, 60, 91). In particular, a recent study
examining purified Drosophila heat shock factor (HSF) re-
ported that trimerization and DNA binding activities could be
induced directly in vitro by heat and by oxidation, but not by a
myriad of other environmental stresses, including arsenite
(91). We therefore sought to test whether BRG1 or BRM
complexes contribute to hsp70 activation by heat shock. Previ-
ous work in both yeasts and mammals has demonstrated that
different heat shock protocols result in differences in activation
of the stress response (18, 47, 66, 67, 92). Initial experiments
designed to optimize heat shock in our cells revealed that
greater activation of hsp70 could be achieved by transferring
the cells from 37 to 32°C for 16 h prior to heat shock at 42°C
than was observed when the cells were moved directly from 37
to 42°C (data not shown). Thus, we chose to focus on this
particular heat shock regimen. Repeated analysis of heat shock
activation of hsp70 in the presence or absence of tetracycline
indicated that expression of dominant negative BRG1 or
hBRM had no effect on the hsp70 levels present in either the
tet-VP16 cells or in any of the mutant cell lines (data not
shown). To confirm that there was no effect on hsp70 activation
by this heat shock protocol, experiments in which side-by-side
comparisons of heat shock and sodium arsenite stimulation
were performed. Cell lines were placed in media either with or
without tetracycline, and half of the samples were transferred
to 32°C at day 3.3. On day 4, cells left at 37°C were treated with
sodium arsenite as described above, while the cells at 32°C
were subjected to heat shock by quickly replacing the media
with media prewarmed to 42°C and placing the cells in a 42°C
incubator for 2 h. Plates were harvested for RNA or protein
extraction, and primer extension and Western analysis of the
f-BRG1 mutant lines are presented in Fig. 6A and B, while
analysis of the f-hBRM mutant lines are presented in Fig. 6C
and D. hsp70 mRNA levels in heat-shocked B22 and B24 cells
were equivalent in the presence or absence of tetracycline,
whereas arsenite-treated B22 and B24 cells clearly showed a
reduction in hsp70 mRNA levels in the absence of tetracycline.
Similarly, no significant difference in the mRNA levels induced
in heat-shocked H17 and H16 cells was observed while arsen-
ite-treated H17 and H16 cells expressing mutant hBRM pro-
tein produced lower levels of hsp70 mRNA. Quantification of
the heat shock experiments (Fig. 6E) indicated that expression
of the mutant Flag-tagged proteins clearly did not cause a
decrease in hsp70 levels, indicating that induction of hsp70 by
heat was not affected by the presence of ATPase-deficient
BRG1 or hBRM molecules in the cells. This strongly suggests
that at least under the heat shock conditions employed, acti-
vation of hsp70 by heat shock is not dependent on BRG1 or
BRM complexes. These results also add to the evidence that
there are multiple activation pathways that can result in the
induction of hsp70 mRNA.
The transcriptional activation of hsp genes in eukaryotes is
mediated through the activity of heat shock factor 1 (HSF1). In
unstimulated mammalian cells, HSF1 is found in a monomeric
state in the cytoplasm. This form of HSF1 is incapable of
binding to its cognate binding site in hsp promoters. Activation
of the heat shock, or stress response, results in multiple post-
translational events that affect HSF1, including homotrimer-
ization, translocation to the nucleus, phosphorylation, and ac-
quisition of DNA binding and transcriptional competence
(reviewed in references 40, 45, 46, 80, and 85). To rule out the
possibility that the effects of dominant negative hBRM and
BRG1 on activation of hsp70 by arsenite or cadmium were
indirectly caused by effects on HSF1 levels, Western analyse
were performed to analyze HSF1 in arsenite-treated cells (Fig.
7). The results demonstrate that neither arsenite nor induction
FIG. 5. Expression of Flag-tagged mutant BRG1 or hBRM partially inhibits
cadmium chloride-mediated activation of hsp70. Growth of cell lines and RNA
and Western analysis were performed as described for Fig. 5 except that cells
were treated on day 4 with 20 mM CdCl2 for 24 h prior to harvesting. M,
mock-treated cells; C, cadmium-treated cells. (C) Quantification of the decrease
in activation of hsp70 by CdCl2 in the presence of the dominant negative pro-
teins. Data points with error bars represent the average of three or four exper-
iments; those without error bars are the average of two experiments.
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of the dominant negative proteins affects HSF1 levels or the
extent of posttranslational modifications that result in altered
HSF1 mobility. Identical results were obtained when cadmium-
treated cells were analyzed (data not shown). Thus, the ob-
served decreases in hsp70 activation are not due to indirect
effects of the dominant negative hBRM and BRG1 on the
HSF1 transcriptional activator.
To further address the generality of a role for BRG1 and
BRM complexes in gene activation, we analyzed the expression
of the HO-1 promoter. Like hsp70, HO-1 can be activated by
both arsenite and cadmium. Treatment of cells with either
arsenite or cadmium revealed a significant induction of HO-1
gene expression; however, induction was unaffected by the
expression of the mutant hBRM or BRG1 (Fig. 8A and B). We
also analyzed expression of Mt I in CdCl2-treated cells. Mt I is
induced by the presence of Cd21 (15, 42), though the absolute
activation of Mt I is lower in 3T3-based cells than in other cell
types (42) and is considerably lower than the activation of
hsp70 or HO-1. Primer extension analysis of Mt I revealed that
the expression of f-BRG1 or f-hBRM mutant proteins had no
effect on the induction of Mt I by Cd21 (Fig. 8C and D). We
conclude that not all activation events induced by arsenite or
Cd21 require BRG1 or BRM complexes, and we suggest that
the involvement of BRG1 and BRM is restricted to a subset of
gene activation events.
FIG. 6. Expression of Flag-tagged mutant BRG1 or hBRM does not affect
heat-shock-mediated activation of hsp70. Cell lines were placed into media either
containing or lacking tetracycline. Sixty-eight hours later, half of the samples
were placed at 32°C. At 84 h postpassage, the media from the cells placed at 32°C
were replaced with media preheated to 42°C. The cells were then placed at 42°C
for 2 h. Cell lines that had remained at 37°C were treated with 100 mM sodium
arsenite for 8 h. Total cellular RNA was prepared, protein extracts were made
from duplicate plates, and RNA and Western analyses were performed as de-
scribed for Fig. 5. M, mock-treated cells; HS, heat-shocked cells; A, arsenite-
treated cells. (E) Quantification of the decrease in activation of hsp70 by heat
shock in the presence of the dominant negative proteins. Data points with error
bars represent the average of three to five experiments; those without error bars
are the average of two experiments.
2846 DE LA SERNA ET AL. MOL. CELL. BIOL.
The effects of mutant hBRM and BRG1 expression on ex-
pression of constitutively active genes were also examined.
Figures 3 to 6 and 8 show that levels of GAPDH were unaf-
fected by the expression of the mutant complexes. This was
confirmed by Northern analysis of RNA from cells maintained
4 days in the absence or presence of tetracycline (Fig. 9). We
also determined that expression of b-actin, nucleolin, and the
28S and 18S rRNAs were largely unaffected by expression of
the mutant complexes. Analysis of fibronectin mRNA levels
showed a slight (less than twofold) decrease in the presence of
either dominant negative protein. In contrast, analysis of major
histocompatibility complex class I mRNA levels showed a
slight increase in the presence of the dominant negative pro-
teins (Fig. 9). These results suggest that mammalian SWI-SNF
FIG. 7. HSF1 levels are unaffected by arsenite stimulation or by expression of mutant hBRM or BRG1. Cell extracts described for Fig. 4 were utilized for Western
analysis with anti-HSF1 antibody.
FIG. 8. Expression of Flag-tagged mutant BRG1 or hBRM does not affect activation of HO-1 by arsenite or cadmium or cadmium-mediated activation of Mt I.
Growth of cell lines and RNA and Western analyses were performed as described for Fig. 4. (A) Primer extension analysis of HO-1 expression. Cells were treated on
day 4 with 20 mM CdCl2 or 100 mM sodium arsenite in serum-free media for 3 h as previously described (1); primer extension analysis used primers complementary
to mouse GAPDH and mouse HO-1. (C) Primer extension analysis of Mt I expression. Cells were treated on day 4 with 20 mM CdCl2 for 8 h prior to harvesting, and
primer extension analysis used primers complementary to mouse GAPDH and mouse Mt I (19). Cells were treated with cadmium chloride for 8 h instead of 24 h as
was done in Fig. 5 because a time course of Cd21-mediated induction of Mt I indicated that Mt I levels were slightly higher at 8 h than they were at 24 h (data not
shown). (B and D) Western analysis to confirm the expression of Flag-tagged mutant BRG1 or hBRM in each sample. M, mock-treated cells; A, arsenite-treated cells;
C, cadmium-treated cells.
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complexes can slightly affect the levels of constitutively ex-
pressed genes in some cases but are unlikely to play a signifi-
cant role in mediating constitutive gene expression.
DISCUSSION
Prior work on mammalian SWI-SNF complexes has identi-
fied subunits, roles in cell growth and in cell cycle progression,
and possible mechanisms by which the complexes cause ATP-
dependent alterations of chromatin structure (reviewed in ref-
erences 23, 30, 32, 83, and 84). A more limited number of
studies have identified transcription factors affected by SWI-
SNF complexes; these studies have largely utilized transient
expression of reporter constructs to implicate SWI-SNF com-
ponents in activation by nuclear hormone receptors and by the
c-myc protein and in repression by the E2F regulator (9, 10, 29,
51, 73). Additionally, work by Fryer and Archer has shown that
chromatin remodeling and transcriptional activation of inte-
grated mouse mammary tumor virus LTR sequences by GR
correlates with hormone-dependent association of GR and
mammalian SWI-SNF components, strongly suggesting a role
for mammalian BRG1 complex in activation of the viral LTR
(17). However, to date only two studies have examined the
regulation of an endogenous cellular gene by mammalian SWI-
SNF components. Introduction of BRG1 to BRG1-deficient
cell lines impaired the induction of the c-fos gene by forskolin
or interleukin-6 by three- to fourfold (52), while the activation
of some myeloid-specific genes was facilitated by mammalian
SWI-SNF proteins (33).
Here, we provide evidence that mammalian SWI-SNF com-
plexes contribute to the transcriptional activation of an endog-
enous hsp70 locus. We report that activation of hsp70 by a
metabolic inhibitor or by a heavy metal, but not by heat stress,
is impaired when mutant BRG1 or hBRM proteins are exog-
enously expressed. Additionally, activation of the HO-1 and
Mt I genes by arsenite and/or cadmium was unaffected by the
expression of the mutant BRG1 and hBRM proteins.
Our demonstration that mammalian SWI-SNF complexes
play a role in hsp70 activation by arsenite or Cd21 is based on
observations that exogenous expression of hBRM or BRG1
proteins that are mutated in the ATP binding site can inhibit
hsp70 activation. Our data strongly suggest that the mutant
form of the protein is interfering with a normal function that
contributes to transcriptional activation. Demonstration that
the exogenously expressed BRG1 and hBRM mutant proteins
could be coimmunoprecipitated with endogenous ini1 and
SWI3 subunits (Fig. 2), which are common to both BRG1 and
BRM complexes, suggests that the mutant proteins are being
assembled into SWI-SNF complexes in the cells. We have not
determined whether all of the endogenous SWI-SNF subunits
are associated with the mutant proteins; therefore, we cannot
state that complete complexes are forming around the non-
functional ATPase subunits. However, stable, inducible ex-
pression of the mutant subunits coupled with their association
with the endogenous ini1 and SWI3 proteins suggests that the
interference in hsp70 activation that we observed is accom-
plished via a dominant negative mechanism. We can envision
two possible mechanisms by which interference of gene expres-
sion by the putative dominant negatives may occur. In one
scenario, a complete SWI-SNF complex forms around the mu-
tant ATPase subunits, forming a SWI-SNF complex incapable
of ATP binding and therefore incapable of ATP hydrolysis and
ATP-dependent chromatin remodeling. This complex is likely
to be targeted to appropriate places in the genome, where it
would fail to function, presumably in some event involving the
remodeling of nucleosome structure. Another possibility is that
incomplete SWI-SNF complexes form around the mutant
ATPase subunits, thereby depleting the wild-type endogenous
BRG1 and BRM proteins of one or more of their associated
subunits and rendering the endogenous complex nonfunc-
tional. These possibilities are not mutually exclusive; a combi-
nation of these events may also occur.
Since the BRG1 and BRM proteins form separate com-
plexes that appear to share the same subunits, it is not possible
for us to determine whether the BRG1 complex, the BRM
complex, or both complexes contribute to activation of hsp70.
One could imagine, for example, that only the BRG1 complex
was specifically responsible for contributing to hsp70 activation
and that expression of the mutant BRG1 inhibited hsp70 acti-
vation by either of the mechanisms outlined above. However,
even if the BRM complex played no role whatsoever in gene
activation, expression of the BRM mutant could still sequester
subunits from the endogenous BRG1 complex, thereby reduc-
ing its ability to activate hsp70. Other methods that specifically
affect only one of the complexes (e.g., cell lines deficient in
BRG1 or BRM) will have to be employed to distinguish which
complex(es) contributes to hsp70 activation.
We have examined the involvement of mammalian SWI-
SNF complexes in the activation of hsp70 by three distinct
classes of stress inducers: arsenite, a metabolic inhibitor; Cd21,
a heavy metal; and heat stress. Expression of mutant SWI-SNF
subunits resulted in impaired activation of hsp70 when induced
by arsenite and Cd31, but there was no effect when heat was
FIG. 9. Northern analysis of constitutively expressed genes. RNA was iso-
lated from cells maintained in the presence or absence of tetracycline for 4 days.
Ethidium bromide staining of rRNA is shown. cDNA probes for rat b-actin,
fibronectin and nucleolin, and for mouse GAPDH and major histocompatibility
complex (MHC) class I were used to probe the blot for the corresponding
mRNAs. Duplicate plates were extracted for Western analysis of Flag-tagged
proteins as described above.
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the stress applied. The simplest interpretation of these results
is that activation by arsenite and Cd21 involves the activity of
mammalian SWI-SNF complexes, but the complexes are not
involved in activation by heat. An alternative explanation is
that SWI-SNF complexes are involved in the activation of
hsp70 in response to elevated temperature, but that there exist
other activities in the cell, perhaps other complexes that affect
chromatin structure, that can fully substitute when the SWI-
SNF complexes are impaired. A third possibility is that the
method used to accomplish heat shock (transfer from 37 to
32°C for 16 h prior to heat shock at 42°C) somehow alleviates
the requirement for SWI-SNF complexes and that expression
of the mutant BRG1 or hBRM proteins in the presence of
other heat shock regimens impairs hsp70 activation. This pos-
sibility has not been examined experimentally. Either way, our
results suggest that there are multiple mechanisms by which
hsp70 activation can be accomplished and that the requirement
for SWI-SNF complexes is specific to distinct activation path-
ways.
Multiple lines of evidence from the literature support the
idea that different inducers of the stress response utilize dif-
ferent activation pathways. First is the obvious difference in
response time to heat stress as opposed to stress by arsenite or
Cd21. The response time to each of these stimuli differs in
different cell types; however, the response to heat is generally
considerably quicker than is the response to most other induc-
ers, including arsenite and Cd21. Second, Mosser et al. (48), in
kinetic studies of the response to heat and Cd21 in HeLa cells,
demonstrated that activation of the stress response by both of
these inducers could occur in the presence of cycloheximide.
Time courses analyzing the activation of HSF binding ability
showed that in cycloheximide-treated, heat-stressed HeLa
cells, activation of HSF binding occurred rapidly, then declined
by 2 h post-heat shock. Addition of cadmium to these cultures
caused reappearance of activated HSF, suggesting that the
activation of HSF binding activity by heat and Cd21 occurs
though independent pathways (48). Other workers have re-
ported that different stresses result in differences in HSF phos-
phorylation (61). In addition, specific mutations in the Schizo-
saccharomyces pombe HSF differentially affect the response to
heat and cadmium stress, again suggesting that activation by
these two inducers can occur via separate pathways (60). Fi-
nally, while it has long been recognized that HSF can be acti-
vated in vitro by heat (36, 47, 93), recent work by Zhong and
colleagues has shown that direct exposure of purified, inactive
Drosophila HSF to a range of other stress inducers, including
arsenite, had no effect on the ability of HSF to trimerize,
whereas heat directly induced HSF trimerization (91). These
results suggest that HSF can directly sense heat but indirectly
senses other activating agents, such as arsenite. Our results,
combined with these prior data, may indicate that inducers that
directly activate HSF may not require the activity of SWI-SNF
complexes while inducers that indirectly activate HSF and the
stress response do show a dependence on SWI-SNF com-
plexes.
How do SWI-SNF complexes contribute to activation of
hsp70 in response to arsenite or Cd21? It has previously been
shown that cycloheximide-treated cells still activate HSF and
hsp transcription when stimulated by Cd21; thus, protein syn-
thesis is not required for the activation process (48). Demon-
strating that HSF1 levels and modifications to HSF1 caused by
arsenite and Cd21 are unaffected by the dominant negative
hBRM and BRG1 (Fig. 7) strongly suggests that the mutant
complexes are not indirectly affecting hsp70 activation by af-
fecting HSF1. Although we cannot rule out the possibility of an
indirect mechanism whereby expression of the dominant neg-
atives inhibits the expression of an uncharacterized, constitu-
tively produced factor(s) that is required for hsp70 activation,
we favor a more direct mechanism in which mammalian SWI-
SNF complexes function during hsp70 activation by contribut-
ing to chromatin structural changes at the hsp70 locus, perhaps
in combination with other ATP-dependent chromatin remod-
elers or other chromatin-modifying enzymes. Our previous in
vitro work showing that addition of hSWI-SNF complex facil-
itates transcriptional elongation on reconstituted hsp70 chro-
matin templates (4) further supports the idea that mammalian
SWI-SNF complexes may act directly at the hsp70 gene.
In the inactive state, the hsp70 locus in Drosophila and hu-
man cells contains a transcriptionally engaged RNA polymer-
ase II (pol II) and a nascent transcript of about 25 to 50 bases
(4, 57). The polymerase at these loci is stalled but is competent
to resume transcription upon activation of the stress response.
Prior work has shown that the presence of nucleosomes down-
stream of the transcription initiation site contributes to pausing
by eukaryotic polymerases (26, 27), suggesting that nucleo-
some structure on the hsp70 gene may contribute to the for-
mation of the paused polymerase. Activation of HSF and the
stress response results in an increase in transcription initiation
as well as a release of the paused polymerase, generating an
increase in the level of full-length hsp70 transcripts (4, 57). In
vitro studies using a reconstituted nucleosomal hsp70 template
have provided evidence that hSWI-SNF complexes stimulate
the ability of the HSF activation domain to promote elongation
(4, 6). In vivo studies have shown that activation of the stress
response also results in an alteration in chromatin structure for
hundreds of base pairs downstream of the hsp70 transcription
initiation site, as reflected by increased nuclease sensitivity in
response to heat shock directed transcription (5). Thus, HSF
facilitates hsp70 transcription by increasing both transcription
initiation as well as facilitating transcription elongation. SWI-
SNF complex contributions to the activation of hsp70 could
occur by altering chromatin structure to facilitate transcription
initiation, transcription elongation, or both.
We have demonstrated that mammalian SWI-SNF com-
plexes contribute to the activation of the endogenous hsp70
gene and that the requirement for the complexes is specific for
particular inducers of the hsp70 expression. This is the first
demonstration that an ATP-dependent chromatin-remodeling
complex is involved in the activation of the stress response
genes in vivo. We have also demonstrated that the involvement
of SWI-SNF complexes can be gene specific, as arsenite- or
Cd21-treated cells require SWI-SNF complexes for full activa-
tion of hsp70 but not for activation of the HO-1 or Mt I
promoters. Additionally, expression of the mutant BRG1 or
hBRM had no or minimal effects on constitutive pol I or pol II
gene expression. Most constitutively expressed genes are
thought to be fixed in an open chromatin structure; our results,
perhaps not surprisingly, suggest that ATP-dependent chroma-
tin-remodeling complexes are not required for the constitutive
expression of these genes. We propose that the involvement of
SWI-SNF complexes in gene activation in mammalian cells will
be determined both by the particular chromatin structure of
the induced gene as well as by the signaling pathway utilized by
the cell to promote activation. We are currently examining this
hypothesis by examining the role of hBRM- and BRG1-based
chromatin-remodeling complexes in other gene induction
events.
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